{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:07:13Z","timestamp":1790885233397,"version":"4.1.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Diphenylcyclopropenone (DPCP) is an effective treatment in severe alopecia areata (AA). Platelet-rich plasma (PRP) has been introduced as an effective modality in AA. We present the first study to evaluate and compare the efficacy and tolerability of DPCP alone and DPCP in combination with PRP in the treatment of severe AA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This is a comparative, randomized, double-blind study that included 14 patients with severe AA. Participants received weekly DPCP plus monthly PRP to treat alopecia patches on one side of their scalp (group 1) and DPCP plus placebo on the other side (group 2). Patient\u2019s response was evaluated with the severity of alopecia tool (SALT) score and trichoscopy scores. PRP was injected for 3 times and patients were followed for 6 months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Among enrolled patients, 7 (50%) experienced a hair regrowth &gt;50%. The mean SALT score and trichoscopy scaled scores decreased over time for both the groups. Nevertheless, there were no significant differences between groups. The side effect was not noticeable in either group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>This is the first study to investigate a synergistic effect with DPCP and PRP. According to this study, PRP is ineffective as an adjunct to DPCP for augmenting its effectiveness.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijt.ijt_37_22","type":"journal-article","created":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T15:00:17Z","timestamp":1750690817000},"page":"25-31","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Randomized Controlled Trial Study to Evaluate the Efficacy of Combination Therapy with Diphenylcyclopropenone and Platelet-Rich Plasmain Alopecia Areaata"],"prefix":"10.4103","volume":"17","author":[{"given":"Robabeh","family":"Abedini","sequence":"first","affiliation":[{"name":"Department of Dermatology, Tehran University of Medical Sciences, Razi Hospital, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azadeh","family":"Rezayat","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Tehran University of Medical Sciences, Razi Hospital, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narges","family":"Ghandi","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Tehran University of Medical Sciences, Razi Hospital, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aida","family":"Varghaei","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Tehran University of Medical Sciences, Razi Hospital, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mojtaba","family":"Sedaghat","sequence":"additional","affiliation":[{"name":"Department of Community Medicine, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamidreza","family":"Mahmoudi","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Tehran University of Medical Sciences, Razi Hospital, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,6,23]]},"reference":[{"key":"R1-20250628","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2017.04.1141","article-title":"Alopecia areata:Disease characteristics, clinical evaluation, and new perspectives on pathogenesis","volume":"78","author":"Strazzulla","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"R2-20250628","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1056\/NEJMra1103442","article-title":"Alopecia areata","volume":"366","author":"Gilhar","year":"2012","journal-title":"N Engl J Med"},{"key":"R3-20250628","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s10238-020-00673-w","article-title":"Alopecia areata:A review on diagnosis, immunological etiopathogenesis and treatment options","volume":"21","author":"Sterkens","year":"2021","journal-title":"Clin Exp Med"},{"key":"R4-20250628","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/1346-8138.14283","article-title":"Trichoscopy of alopecia areata:An update","volume":"45","author":"Wa\u015bkiel","year":"2018","journal-title":"J Dermatol"},{"key":"R5-20250628","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/bjd.14497","article-title":"Alopecia areata and health-related quality of life:A systematic review and meta-analysis","volume":"175","author":"Rencz","year":"2016","journal-title":"Br J Dermatol"},{"key":"R6-20250628","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jaad.2017.04.1142","article-title":"Alopecia areata:An appraisal of new treatment approaches and overview of current therapies","volume":"78","author":"Strazzulla","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"R7-20250628","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/bjd.12397","article-title":"Arandomized, double-blind, placebo- and active-controlled, half-head study to evaluate the effects of platelet-rich plasma on alopecia areata","volume":"169","author":"Trink","year":"2013","journal-title":"Br J Dermatol"},{"key":"R8-20250628","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1080\/09546630701846095","article-title":"Combination therapy of cyclosporine and methylprednisolone on severe alopecia areata","volume":"19","author":"Kim","year":"2008","journal-title":"J Dermatolog Treat"},{"key":"R9-20250628","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.jaad.2015.01.008","article-title":"Efficacy and safety of diphenylcyclopropenone alone or in combination with anthralin in the treatment of chronic extensive alopecia areata:A retrospective case series","volume":"72","author":"Durdu","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"R10-20250628","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/sji.12469","article-title":"Complex interaction between diphenylcyclopropenone and immune responses in alopecia areata","volume":"84","author":"Tavakolpour","year":"2016","journal-title":"Scand J Immunol"},{"key":"R11-20250628","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1046\/j.1365-2133.2001.04399.x","article-title":"The therapeutic use of topical contact sensitizers in benign dermatoses","volume":"145","author":"Buckley","year":"2001","journal-title":"Br J Dermatol"},{"key":"R12-20250628","first-page":"357","article-title":"The use of platelet-rich plasma in oral surgery:A systematic review and meta-analysis","volume":"17","author":"Franchini","year":"2019","journal-title":"Blood Transfus"},{"key":"R13-20250628","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1177\/1947603516670709","article-title":"PRP for degenerative cartilage disease:A systematic review of clinical studies","volume":"8","author":"Laver","year":"2017","journal-title":"Cartilage"},{"key":"R14-20250628","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3109\/09546634.2015.1094178","article-title":"Applications of platelet-rich plasma in dermatology:A critical appraisal of the literature","volume":"27","author":"Lynch","year":"2016","journal-title":"J Dermatolog Treat"},{"key":"R15-20250628","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1111\/j.1524-4725.2012.02394.x","article-title":"Autologous platelet-rich plasma:A potential therapeutic tool for promoting hair growth","volume":"38","author":"Li","year":"2012","journal-title":"Dermatol Surg"},{"key":"R16-20250628","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jaad.2003.09.032","article-title":"Alopecia areata investigational assessment guidelines \u2013Part II. National alopecia areata foundation","volume":"51","author":"Olsen","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"R17-20250628","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/j.yexcr.2012.05.003","article-title":"VEGF induces proliferation of human hair follicle dermal papilla cells through VEGFR-2-mediated activation of ERK","volume":"318","author":"Li","year":"2012","journal-title":"Exp Cell Res"},{"key":"R18-20250628","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1111\/jocd.12919","article-title":"The mechanism of activated platelet-rich plasma supernatant promotion of hair growth by cultured dermal papilla cells","volume":"18","author":"Xiao","year":"2019","journal-title":"J Cosmet Dermatol"},{"key":"R19-20250628","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1016\/j.jisp.2020.05.008","article-title":"Monitoring response to platelet-rich plasma in patients with alopecia areata with optical coherence tomography:A case series","volume":"20","author":"Ekelem","year":"2020","journal-title":"J Investig Dermatol Symp Proc"},{"key":"R20-20250628","doi-asserted-by":"crossref","first-page":"e12437","DOI":"10.1111\/dth.12437","article-title":"Platelets rich plasma versus minoxidil 5% in treatment of alopecia areata:a trichoscopic evaluation","volume":"30","author":"El Taieb","year":"2017","journal-title":"Dermatologic therapy"},{"key":"R21-20250628","doi-asserted-by":"crossref","first-page":"928030","DOI":"10.1155\/2010\/928030","article-title":"Cytokines and other mediators in alopecia areata","volume":"2010","author":"Gregoriou","year":"2010","journal-title":"Mediators Inflamm"},{"key":"R22-20250628","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jaad.2017.03.015","article-title":"Systematic review and quality analysis of studies on the efficacy of topical diphenylcyclopropenone treatment for alopecia areata","volume":"77","author":"Jang","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"R23-20250628","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1054\/jcms.2002.0285","article-title":"Growth factor levels in platelet-rich plasma and correlations with donor age, sex, and platelet count","volume":"30","author":"Weibrich","year":"2002","journal-title":"J Craniomaxillofac Surg"},{"key":"R24-20250628","doi-asserted-by":"crossref","first-page":"213","DOI":"10.4103\/0974-2077.150743","article-title":"Study of platelet-rich plasma injections in the treatment of androgenetic alopecia through an one-year period","volume":"7","author":"Gkini","year":"2014","journal-title":"J Cutan Aesthet Surg"},{"key":"R25-20250628","doi-asserted-by":"crossref","first-page":"e14388","DOI":"10.1111\/dth.14388","article-title":"A randomized, placebo and active controlled, split scalp study to evaluate the efficacy of platelet-rich plasma in patchy alopecia areata of the scalp","volume":"33","author":"Hegde","year":"2020","journal-title":"Dermatol Ther"},{"key":"R26-20250628","doi-asserted-by":"crossref","first-page":"920","DOI":"10.4103\/idoj.IDOJ_6_20","article-title":"A comparative study of therapeutic response to intralesional injections of platelet-rich plasma versus triamcinolone acetonide in alopecia areata","volume":"11","author":"Balakrishnan","year":"2020","journal-title":"Indian Dermatol Online J"},{"key":"R27-20250628","doi-asserted-by":"crossref","first-page":"103","DOI":"10.4103\/JCAS.JCAS_16_19","article-title":"Comparative evaluation of therapeutic efficacy of intralesional injection of triamcinolone acetonide versus intralesional autologous platelet-rich plasma injection in alopecia areata","volume":"13","author":"Kapoor","year":"2020","journal-title":"J Cutan Aesthet Surg"},{"key":"R28-20250628","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/0190-9622(93)70238-O","article-title":"Treatment of chronic severe alopecia areata with topical diphenylcyclopropenone and 5% minoxidil:A clinical and immunopathologic evaluation","volume":"29","author":"Shapiro","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"R29-20250628","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1365-2230.1991.tb00339.x","article-title":"Treatment of alopecia totalis with a combination of inosine pranobex and diphencyprone compared to each treatment alone","volume":"16","author":"Berth-Jones","year":"1991","journal-title":"Clin Exp Dermatol"},{"key":"R30-20250628","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s00403-019-01940-x","article-title":"Efficacy and safety of anthralin in combination with diphenylcyclopropenone in the treatment of alopecia areata:A retrospective case series","volume":"311","author":"Nasimi","year":"2019","journal-title":"Arch Dermatol Res"}],"container-title":["International Journal of Trichology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijt.ijt_37_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:35:14Z","timestamp":1787067314000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijt.ijt_37_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/ijt.ijt_37_22","relation":{},"ISSN":["0974-7753","0974-9241"],"issn-type":[{"value":"0974-7753","type":"print"},{"value":"0974-9241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"2022-03-22","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-31","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}